Effects of an Oral Contraceptive Containing Drospirenone on Bone Turnover and Bone Mineral Density
- 1 January 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 105 (1), 53-60
- https://doi.org/10.1097/01.aog.0000148344.26475.fc
Abstract
To compare the effects of a new 21-day combined oral contraceptive containing 30 microg ethinyl/estradiol plus 3 mg drospirenone with a 21-day preparation containing 30 microg ethinyl/estradiol plus 75 microg gestodene on bone turnover and bone mineral density in young fertile women. A randomized, controlled trial was conducted with healthy fertile women treated with 30 microg ethinyl/estradiol plus 3 mg drospirenone (group A; n = 24), 30 microg ethinyl/estradiol plus 75 microg gestodene (group B; n = 24) and healthy controls (group C, n = 23). At 3, 6, 9, and 12 months of the study, serum and urinary calcium, osteocalcin, urinary pyridinoline, and deoxypyridinoline were measured. At baseline and after 12 months, lumbar bone mineral density was determined by dual-energy X-ray absorptiometry. In groups A and B, urinary pyridinoline and deoxypyridinoline at 6, 9, and 12 months were significantly reduced in comparison with basal values and group C (P < .05). Pyridinoline and deoxypyridinoline levels were lower in group A than in group B throughout the study, but not significantly. In group A serum calcium levels were significantly increased after 6 months. At 12 months, no significant difference was detected in lumbar bone mineral density values among the 3 groups and in comparison with basal values. Both combined oral contraceptives exert a similar positive influence on bone turnover and bone-sparing effect in young postadolescent women.Keywords
This publication has 28 references indexed in Scilit:
- Sex Steroids and BonePhysiological Reviews, 2001
- Lower peak bone mass and its declineBest Practice & Research Clinical Endocrinology & Metabolism, 2000
- Biochemical aspects of hormonal contraception: Effects on bone metabolismThe European Journal of Contraception & Reproductive Health Care, 1997
- The effect of previous oral contraceptive use on bone mineral density in perimenopausal womenOsteoporosis International, 1994
- Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: A prospective studyContraception, 1993
- Lack of relationship between hip and spine bone mineral density and oral contraceptive useEuropean Journal of Clinical Investigation, 1993
- Oral Contraceptive Use May Protect Against Low Bone MassArchives of Internal Medicine, 1991
- Bone density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth-control pillsThe American Journal of Clinical Nutrition, 1991
- Long-term oral contraceptive use does not affect trabecular bone densityAmerican Journal of Obstetrics and Gynecology, 1989
- The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal womenContraception, 1986